AmitBangaMD

Pulmonology • Stanford, CA

Critical Care Medicine, Pleural Disease

Physician

Join to view full profile

Dr. Banga is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Banga's full profile

Already have an account?

Office
300 Pasteur Dr
Stanford, CA 94305
Phone+1 650-723-4000

Fax+1 214-645-2808

Education & Training

Cleveland Clinic FoundationFellowship, Pulmonary Disease and Critical Care Medicine, 2011 - 2014
Sparrow Hospital/Michigan State UniversityResidency, Internal Medicine, 2008 - 2011
The MetroHealth System/Case Western Reserve UniversityResidency, Internal Medicine, 2007 - 2007
Drexel University College of Medicine/Hahnemann University HospitalResidency, Internal Medicine, 2005 - 2006
Gajra Raja Medical CollegeClass of 1997

Certifications & Licensure

CA State Medical License 2022 - 2026
TX State Medical License 2014 - 2026
OH State Medical License 2007 - 2014
MI State Medical License 2008 - 2012

Publications & Presentations

PubMed

Outpatient management of Post-COVID syndrome - single center experience.
Fernando Torres, Christine Shedd, Vaidehi Kaza, Srinivas Bollineni, Amit Banga
Heart & Lung. 2024-05-16
Crossroads between Autoimmunity and COVID-19 in Lung Transplant Recipients.
Madhusudhanan Narasimhan, Alagarraju Muthukumar, Kavithalakshmi Sataranatarajan, Lenin Mahimainathan, Luke Mahan
Viruses. 2023-10-03
2 citations
Delayed-Onset Psychosis Secondary to Tacrolimus Neurotoxicity After Lung Transplant: A Case Report and Systematic Review.
Matthew Gunther, Shixie Jiang, Amit Banga, Yelizaveta Sher
Journal of the Academy of Consultation-Liaison Psychiatry. 2023-09-29

Press Mentions

Lung Transplantation in the Era of COVID-19: New Issues and ParadigmsDecember 13th, 2021
Lung Transplantation for Patients with Severe COVID-19October 12th, 2021
Cancer Researchers Find up to One-Quarter of Lung Cancer Patients May Be Ineligible for Immunotherapy (The University of Texas Southwestern Medical Center at Dallas)June 4th, 2016